跳转至内容
Merck

I6034

Sigma-Aldrich

α- L -艾杜糖醛酸酶 人

recombinant, expressed in mouse NSO cells

别名:

IDUA

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352204
NACRES:
NA.54

重組細胞

expressed in mouse NSO cells

品質等級

形狀

solution

比活性

≥7,500 units/μg protein

分子量

83 kDa

雜質

≤1.0 EU/μg Endotoxin

運輸包裝

wet ice

儲存溫度

−20°C

一般說明

α-L-艾杜糖苷酸酶 (IDUA) 定位于人染色体4p16.3。成熟的IDUA蛋白被糖基化,并包含三糖磷酸异构酶(TIM)桶状结构域、β夹心式螺旋-环-螺旋区域和免疫球蛋白样结构域。α-L-艾杜糖苷酸酶被归类为糖苷水解酶(GH)家族39。

應用

α-L-艾杜糖醛酸酶可用于新生儿 a-L-艾杜糖醛酸酶缺乏症的白细胞测定。

生化/生理作用

α-L-艾杜糖苷酸酶突变与粘多糖贮积病I型(MPS I)有关。该酶的缺陷导致皮肤素和硫酸乙酰肝素的积累。MPS I的病理生理学伴随着颅骨变形、智力低下和疝气。
在溶酶体降解过程中,α-L-艾杜糖苷酸酶(Iduronidase )起着至关重要的作用。它水解糖胺聚糖(GAG)(包括硫酸皮肤素和硫酸乙酰肝素) 中非还原末端的α L-艾杜糖醛酸残基。
催化硫酸皮肤素中未硫酸化的 L -艾杜糖苷键的水解

物理性質

在 SDS-PAGE 还原条件下,表达为 C-末端组氨酸标记蛋白(残基 1-653),其含钙核分子量为 71 kDa,在约 83 kDa 处迁移。

單位定義

一个单元将在-25°C pH 3.5 下每分钟从 4-甲基伞形酮-α-L-艾杜糖苷酸生成 1 皮摩尔的 4-甲基伞形酮。

外觀

40 mM 醋酸钠、400 mM NaCl 和 20% (v/v) 甘油溶液 (pH 5.0)

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Kristin D'Aco et al.
European journal of pediatrics, 171(6), 911-919 (2012-01-12)
Our objective was to assess how the diagnosis and treatment of mucopolysaccharidosis I (MPS I) have changed over time. We used data from 891 patients in the MPS I Registry, an international observational database, to analyze ages at symptom onset
Akemi Tanaka et al.
Molecular genetics and metabolism, 107(3), 513-520 (2012-10-02)
Hematopoietic stem cell transplantation (HSCT) has not been indicated for patients with mucopolysaccharidosis II (MPS II, Hunter syndrome), while it is indicated for mucopolysaccharidosis I (MPS I) patients <2 years of age and an intelligence quotient (IQ) of ≥ 70.
Ruben J Boado et al.
Bioconjugate chemistry, 24(1), 97-104 (2012-12-20)
The chronic administration of recombinant fusion proteins in preclinical animal models may generate an immune response and the formation of antidrug antibodies (ADA). Such ADAs could alter the plasma pharmacokinetics of the fusion protein, and mask any underlying toxicity of
Minke H de Ru et al.
Orphanet journal of rare diseases, 7, 22-22 (2012-04-25)
Mucopolysaccharidosis type I (MPS I) is traditionally divided into three phenotypes: the severe Hurler (MPS I-H) phenotype, the intermediate Hurler-Scheie (MPS I-H/S) phenotype and the attenuated Scheie (MPS I-S) phenotype. However, there are no clear criteria for delineating the different
Xu He et al.
Nature communications, 3, 1062-1062 (2012-09-20)
Lysosomal storage diseases are a class of over 70 rare genetic diseases that are amenable to enzyme replacement therapy. Towards developing a plant-based enzyme replacement therapeutic for the lysosomal storage disease mucopolysaccharidosis I, here we expressed α-L-iduronidase in the endosperm

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门